The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Rebrov A.P.

Saratov State Medical University named after V.I. Razumovskyy

Coronary microvascular dysfunction in rheumatic diseases — what do we know today?

Authors:

Rebrov A.P.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2024;27(9): 138‑143

DOI: 10.17116/profmed202427091138

Read: 1429 times

Download PDF (RU)
Contact the author
Table of contents

CORONARY MICROVASCULAR DYSFUNCTION IN RHEUMATIC DISEASES — WHAT DO WE KNOW TODAY?
CORONARY MICROVASCULAR DYSFUNCTION IN RHEUMATIC DISEASES — WHAT DO WE KNOW TODAY?

To cite this article:

Rebrov AP. Coronary microvascular dysfunction in rheumatic diseases — what do we know today? Russian Journal of Preventive Medicine. 2024;27(9):138‑143. (In Russ.)
https://doi.org/10.17116/profmed202427091138

 
Подписка 2026 Профилактическая медицина (Russian Journal of Preventive Medicine)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Modern view on the possibilities of patients with rheumatoid arthritis remote treatment moni­toring. Russian Journal of Preventive Medi­cine. 2024;(11):40-45
The role of systemic and local immu­nity in the pathogenesis of endo­metriosis of varying degrees of prevalence of the process: a modern view. Russian Journal of Human Reproduction. 2024;(5):6-14
High mobi­lity group protein B1 (HMGB1) and the pote­ntial for inflammation amplification in preeclampsia and threatened preterm labor. Russian Journal of Human Reproduction. 2024;(5):82-88
Perioperative prevention of bleeding in glaucoma surgery. Russian Annals of Ophthalmology. 2024;(5):118-124
The rela­tionship between inflammatory markers, fati­gue, and effort-based deci­sion-making in patients at clinical high risk for psychosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):85-91
Effi­cacy of alpha-glutamyl-tryptophan in the treatment of chro­nic atro­phic gastritis: case series. Russian Journal of Evidence-Based Gastroenterology. 2024;(4):121-128
Neuropeptide Y and inflammatory indi­ces in women after repeated cesa­rean section. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):35-40
Anti­fungal immu­nity in patients with chro­nic rhinosinusitis with nasal polyps. Russian Bulletin of Otorhinolaryngology. 2024;(6):40-45
Functional cyto­kine redu­ndancy in pregnancy. Russian Journal of Human Reproduction. 2024;(6):73-80
Effect of pro-inflammatory cyto­kines TNF-a and IL-1b on endo­thelial cells. Russian Cardiology Bulletin. 2024;(4-2):121-127
Abstract:

The article presents data on features of coronary microvascular dysfunction development in some autoimmune rheumatic diseases, namely systemic lupus erythematosis, rheumatoid arthritis, systemic sclerosis, vasculitides. The role of inflammation was discussed, the possible effect of anti-inflammatory therapy was analyzed.

Keywords:

coronary microvascular dysfunction
inflammation
rheumatoid arthritis
systemic lupus erythematosis
systemic sclerosis
systemic vasculitides

Authors:

Rebrov A.P.

Saratov State Medical University named after V.I. Razumovskyy

Received:

21.03.2024

Accepted:

07.05.2024

Close metadata

References:

  1. Rehan R, Yong A, Ng M, et. al. Coronary microvascular dysfunction: A review of recent progress and clinical implications. Frontiers in Cardiovascular Medicine. 2023;10:1111721. https://doi.org/10.3389/fcvm.2023.1111721
  2. Del Buono MG, Montone RA, Camilli M, et al. Coronary Microvascular Dysfunction across the Spectrum of Cardiovascular Diseases: JACC State-of-the-Art Review. Journal of the American College of Cardiology. 2021;78(13): 1352-1371. https://doi.org/10.1016/j.jacc.2021.07.042
  3. Zanatta E, Colombo C, D’Amico G, et al. Inflammation and Coronary Microvascular Dysfunction in Autoimmune Rheumatic Diseases. International Journal of Molecular Sciences. 2019;20(22):5563. https://doi.org/10.3390/ijms20225563
  4. Pepine CJ, Anderson RD, Sharaf BL, et al. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women’s Ischemia Syndrome Evaluation) study. Journal of the American College of Cardiology. 2010;55:2825-2832. https://doi.org/10.1016/j.jacc.2010.01.054
  5. Herrmann J, Kaski JC, Lerman A. Coronary microvascular dysfunction in the clinical setting: from mystery to reality. European Heart Journal. 2012;33: 2771-2782b. https://doi.org/10.1093/eurheartj/ehs246
  6. Konst RE, Guzik TJ, Kaski JC, et al. The pathogenic role of coronary microvascular dysfunction in the setting of other cardiac or systemic conditions. Cardiovascular Research. 2020;116(4):817-828.  https://doi.org/10.1093/cvr/cvaa009
  7. Taqueti VR, Di Carli MF. Coronary microvascular disease pathogenic mechanisms and therapeutic options: JACC state-of-the-art review. Journal of the American College of Cardiology. 2018;72:2625-2641. https://doi.org/10.1016/j.jacc.2018.09.042
  8. Prasad M, Hermann J, Gabriel SE, et al. Cardiorheumatology: Cardiac involvement in systemic rheumatic disease. Nature Reviews. Cardiology. 2015; 12:168-176.  https://doi.org/10.1038/nrcardio.2014.206
  9. Faccini A, Kaski JC, Camici PG. Coronary microvascular dysfunction in chronic inflammatory rheumatoid diseases. European Heart Journal. 2016;37: 1799-1806. https://doi.org/10.1093/eurheartj/ehw018
  10. Dumitriu IE. The life (and death) of CD4+ CD28(null) T cells in inflammatory diseases. Immunology. 2015;146:185-193.  https://doi.org/10.1111/imm.12506
  11. Camici PG, d’Amati G, Rimoldi O. Coronary microvascular dysfunction: Mechanisms and functional assessment. Nature Reviews. Cardiology. 2015;12:48-62.  https://doi.org/10.1038/nrcardio.2014.160
  12. Hokimoto S, Kaikita K, Yasuda S, et al. JCS/CVIT/JCC 2023 guidline focused update on diagnosis and treatment of vasospastic angina (coronary spastic angina) and coronary microvascular dysfunction. Journal of Cardiology. 2023;82(4):293-341.  https://doi.org/10.1016/j.jjcc.2023.06.009VIT/JCC
  13. Rubinshtein R, Yang EH, Rihal CS, et al. Coronary microcirculatory vasodilator function in relation to risk factors among patients without obstructive coronary disease and low to intermediate Framingham score. European Heart Journal. 2010;31:936-942.  https://doi.org/10.1093/eurheartj/ehp459
  14. Vacca A, Siotto P, Cauli A, et al. Absence of epicardial coronary stenosis in patients with systemic sclerosis with severe impairment of coronary flow reserve. Annals of the Rheumatic Diseases. 2006;65:274-275.  https://doi.org/10.1136/ard.2005.040154
  15. Pries AR, Habazettl H, Ambrosio G, et al. A review of methods for assessment of coronary microvascular disease in both clinical and experimental settings. Cardiovascular Research. 2008;80:165-174.  https://doi.org/10.1093/cvr/cvn136
  16. Allanore Y, Meune C. Primary myocardial involvement in systemic sclerosis: Evidence for a microvascular origin. Clinical and Experimental Rheumatology. 2010;28:S48-S53. 
  17. Pintér T, Faludi R, Magyari B, et al. Mechanism of coronary flow reserve reduction in systemic sclerosis: Insight from intracoronary pressure wire studies. Rheumatology (Oxford, England). 2011;50:781-788.  https://doi.org/10.1093/rheumatology/keq402
  18. Galindo M, Chung L, Crockett SD, Chakravarty EF. Coronary artery disease in patients with systemic lupus erythematosus. Nature Clinical Practice. Rheumatology. 2005;1:55-59.  https://doi.org/10.1038/ncprheum0037
  19. Manzi S, Meilahn EN, Rairie JE, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: Comparison with the Framingham Study. American Journal of Epidemiology. 1997;145:408-415.  https://doi.org/10.1093/oxfordjournals.aje.a009122
  20. Hirata K, Kadirvelu A, Kinjo M, et al. Altered coronary vasomotor function in young patients with systemic lupus erythematosus. Arthritis and Rheumatism. 2007;56:1904-1909. https://doi.org/10.1002/art.22702
  21. Yılmaz S, Caliskan M, Kulaksızoglu S, et al. Association between serum total antioxidant status and coronary microvascular functions in patients with SLE. Echocardiography (Mount Kisco, N.Y.). 2012;29:1218-1223. https://doi.org/10.1111/j.1540-8175.2012.01797.x
  22. Ishimori ML, Martin R, Berman DS, et al. Myocardial ischemia in the absence of obstructive coronary artery disease in systemic lupus erythematosus. JACC. Cardiovascular Imaging. 2011;4:27-33.  https://doi.org/10.1016/j.jcmg.2010.09.019
  23. Recio-Mayoral A, Mason JC, Kaski JC, et al. Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease. European Heart Journal. 2009;30:1837-1843. https://doi.org/10.1093/eurheartj/ehp205
  24. Sandhu VK, Wei J, Thomson LEJ, et al. A Five-Year Follow up of Coronary Microvascular Dysfunction and Coronary Artery Disease in SLE: Results from a Community-Based Lupus Cohort. Arthritis Care and Research. 2020; 72(7):882-887.  https://doi.org/10.1002/acr.23920
  25. Guo Q, Wu LM, Wang Z, et al. Early Detection of Silent Myocardial Impairment in Drug-Naive Patients with New-Onset Systemic Lupus Erythematosus: A Three-Center Prospective Study. Arthritis and Rheumatology (Hoboken, N.J.). 2018;70:2014-2024. https://doi.org/10.1002/art.40671
  26. England BR, Thiele GM, Anderson DR, Mikuls TR. Increased cardiovascular risk in rheumatoid arthritis: Mechanisms and implications. BMJ. 2018; 361:k1036. https://doi.org/10.1136/bmj.k1036
  27. Ikonomidis I, Tzortzis S, Andreadou I, et al. Increased benefit of interleukin-1 inhibition on vascular function, myocardial deformation, and twisting in patients with coronary artery disease and coexisting rheumatoid arthritis. Circulation. Cardiovascular Imaging. 2014;7:619-628.  https://doi.org/10.1161/CIRCIMAGING.113.001193
  28. Wright K, Crowson CS, Gabriel SE. Cardiovascular comorbidity in rheumatic diseases: A focus on heart failure. Heart Failure Clinics. 2014;10:339-352.  https://doi.org/10.1016/j.hfc.2013.10.003
  29. Amigues I, Russo C, Giles JT, et al. Myocardial Microvascular Dysfunction in Rheumatoid Arthritis. Circulation. Cardiovascular Imaging. 2019;12:e007495. https://doi.org/10.1161/CIRCIMAGING.117.007495
  30. Zanatta E, Codullo V, Avouac J, Allanore Y. Systemic sclerosis: Recent insight in clinical management. Joint Bone Spine. 2020;87(4):293-299.  https://doi.org/10.1016/j.jbspin.2019.09.015
  31. Long A, Duffy G, Bresnihan B. Reversible myocardial perfusion defects during cold challenge in scleroderma. British Journal of Rheumatology. 1986;25:158-161.  https://doi.org/10.1093/rheumatology/25.2.158
  32. Zanatta E, Famoso G, Boscain F, et al. Nailfold avascular score and coronary microvascular dysfunction in systemic sclerosis: A newsworthy association. Autoimmunity Reviews. 2019;18:177-183.  https://doi.org/10.1016/j.autrev.2018.09.002
  33. Rodríguez-Reyna TS, Morelos-Guzman M, Hernández-Reyes P, et al. Assessment of myocardial fibrosis and microvascular damage in systemic sclerosis by magnetic resonance imaging and coronary angiotomography. Rheumatology (Oxford, England). 2015;54:647-654.  https://doi.org/10.1093/rheumatology/keu350
  34. Zanatta E, Famoso G, Boscain F, et al. Nailfold avascular score and coronary microvascular dysfunction in systemic sclerosis: A newsworthy association. Autoimmunity Reviews. 2019;18:177-183.  https://doi.org/10.1016/j.autrev.2018.09.002
  35. Valentini G, Huscher D, Riccardi A, et al. Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: Results of the DeSScipher inception cohort study. Annals of the Rheumatic Diseases. 2019;78:1576-1582. https://doi.org/10.1136/annrheumdis-2019-215486
  36. Ntusi NA, Piechnik SK, Francis JM, et al. Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis — A clinical study using myocardial T1-mapping and extracellular volume quantification. Journal of Cardiovascular Magnetic Resonance. 2014;16:21.  https://doi.org/10.1186/1532-429X-16-21
  37. Mavrogeni SI, Schwitter J, Gargani L, et al. Cardiovascular magnetic resonance in systemic sclerosis: «Pearls and pitfalls». Seminars in Arthritis and Rheumatism. 2017;47:79-85.  https://doi.org/10.1016/j.semarthrit.2017.03.020
  38. Pieroni M, De Santis M, Zizzo G, et al. Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: Potential utility of immunosuppressive therapy in cardiac damage progression. Seminars in Arthritis and Rheumatism. 2014;43:526-535.  https://doi.org/10.1016/j.semarthrit.2013.07.006
  39. Mueller KA, Mueller II, Eppler D, et al. Clinical and histopathological features of patients with systemic sclerosis undergoing endomyocardial biopsy. PLoS ONE. 2015;10:e0126707. https://doi.org/10.1371/journal.pone.0126707
  40. Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis and Rheumatism. 2013;65:1-11.  https://doi.org/10.1002/art.37715
  41. Bourgarit A, Toumelin PL, Pagnoux C, et al. Deaths occurring during the first year after treatment onset for polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: A retrospective analysis of causes and factors predictive of mortality based on 595 patients. Medicine. 2005;84: 323-330.  https://doi.org/10.1097/01.md.0000180793.80212.17
  42. Hazebroek MR, Kemna MJ, Schalla S, et al. Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: Eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis. International Journal of Cardiology. 2015;199:170-179.  https://doi.org/10.1016/j.ijcard.2015.06.087
  43. Greulich S, Kitterer D, Kurmann R, et al. Cardiac involvement in patients with rheumatic disorders: Data of the RHEU-M(A)R study. International Journal of Cardiology. 2016;224:37-49.  https://doi.org/10.1016/j.ijcard.2016.08.298
  44. Dunogué B, Terrier B, Cohen P, et al. Impact of cardiac magnetic resonance imaging on eosinophilic granulomatosis with polyangiitis outcomes: A long-term retrospective study on 42 patients. Autoimmunity Reviews. 2015;14: 774-780.  https://doi.org/10.1016/j.autrev.2015.04.013
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.